State of the Art: Cardiorenal Syndrome and Hypertensive Heart Disease
Carmine Zoccali
Figure 2. The endogenous NO inhibitor, asymmetric dimethyl arginine (ADMA) downregulates NO synthase (NOS) and NO production, which normally is stimulated by L-arginine.
